English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Valent BioSciences launches new biostimulant operating unit to serve U.S. marketqrcode

Oct. 14, 2022

Favorites Print
Forward
Oct. 14, 2022

Valent BioSciences LLC
United States  United States
Follow

Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forest health, has announced that the company began selling biostimulant products directly to its U.S. customer base on October 1. The new operating unit was established in February 2022 and it is now fully operational, enabling the organization to serve the entire U.S market. This transition marks a major change in the go-to-market strategy for Valent BioSciences, as the company begins selling biostimulant products directly to U.S. channel partners.

The new biostimulant business team and salesforce are focused on discovering, developing, and commercializing arbuscular mycorrhizal fungi (AMF) products, among other biostimulants, to sustainably maximize retailer and grower profitability.

″As both market volatility and the global population increase, biostimulants can be used to sustainably improve crop performance and ROI,″ said Salman Mir, Executive Vice President and Chief Operating Officer at Valent BioSciences. ″Biostimulant products, including our AMF technologies, also support the mission of our parent company, Sumitomo Chemical Co., Ltd., for achieving carbon neutrality by 2050, as well as its global goal of attaining carbon neutrality for society as a whole.″

The core Valent BioSciences biostimulant products are being marketed under the SymvadoTM and ProliantTM brand names. The team is focused on achieving customer success with biostimulants and will be employing a variety of newly created tools and digital assets to support commercialization of these brands in the U.S. market.

″We recognize that biostimulants can be challenging products for customers to successfully utilize, so we are adapting our strategy to best address customer needs and drive value for all parties,″ said Dave Schumacher, Vice President of Commercial Operations for Valent BioSciences.

The new biostimulants business at Valent BioSciences includes numerous technical experts who are available to help retailers and growers navigate this complex market segment.

″We have more than 60 years of broad biorational crop enhancement expertise, and this launch incorporates the next generation of tools to help our customers succeed,″ said Mir. ″We are in an excellent position to lead the biostimulants industry as it transitions to science-driven biostimulant products that positively impact the bottom line.″


0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe BioEx Biweekly to send news related to your mailbox